Client News

Medical technology specialist avateramedical is restructuring through insolvency proceedings

Carbios demonstrates superior performance of its enzyme in world-renowned scientific publication

Mainz Biomed to Showcase ColoAlert® at UEG Week 2023 in Copenhagen, Denmark

BioLizard launches new AI-empowered “BioVerse” platform to facilitate data-driven R&D for global life sciences community

AATec Medical Announces Creation of Scientific Advisory Board

Newron TRS study 6 months’ results: Evenamide substantially improves patients to an extent that they no longer meet protocol entry criteria

Mainz Biomed to Attend the JonesTrading 2023 Healthcare Summit

Rentschler Biopharma and Friedrich-Adler-Realschule Laupheim sign cooperation agreement to enhance school education with additional practical experience

Mainz Biomed Announces Live Launch of ColoAlert® with Bioclinica in Romania

Newron to present three posters on its clinical program evaluating evenamide in the treatment of schizophrenia at the 36th European College of Neuropsychopharmacology Congress